(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-18 View latest technical analysis
10 day averaged volume of Biomarin Pharmaceutical is 3079394
Date | Daily Closing Price | Open | High | Low | Volume |
18 Wed Sep 2024 | 71.14 | 70.87 | 71.58 | 70.11 | 0.705 times |
17 Tue Sep 2024 | 70.55 | 70.00 | 71.64 | 68.83 | 1.51 times |
16 Mon Sep 2024 | 69.86 | 77.53 | 78.00 | 69.60 | 3.436 times |
13 Fri Sep 2024 | 84.90 | 84.43 | 85.00 | 83.95 | 0.388 times |
12 Thu Sep 2024 | 84.38 | 84.83 | 85.00 | 83.91 | 0.483 times |
11 Wed Sep 2024 | 84.78 | 84.72 | 84.94 | 83.43 | 0.472 times |
10 Tue Sep 2024 | 84.85 | 84.48 | 85.64 | 83.69 | 0.643 times |
09 Mon Sep 2024 | 84.33 | 84.28 | 84.84 | 83.45 | 0.548 times |
06 Fri Sep 2024 | 84.08 | 85.33 | 86.04 | 83.73 | 0.513 times |
05 Thu Sep 2024 | 85.12 | 90.01 | 90.01 | 84.89 | 0.792 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 70.4, for a target of 78.6 or 85.5
Share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Target | 68.83 |
Upside Target | 73.68 |
Upside Target | 75.40 |
Upside Target | 78.00 |
Upside Target | 80.06 |
Upside Target | 83.43 |
Upside Target | 88.61 |
Upside Target | 89.95 |
Upside Target | 92.35 |
Upside Target | 92.81 |
Upside Target | 93.04 |
Upside Target | 94.85 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Intraday Target | 67.31 |
Downside Intraday Target | 63.49 |
Upside Intraday Target | 76.48 |
Upside Intraday Target | 81.83 |
Upside Intraday Target | 72.66 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Weekly Closing Price | Open | High | Low | Volume |
18 Wed Sep 2024 | 71.14 | 77.53 | 78.00 | 68.83 | 2.229 times |
13 Fri Sep 2024 | 84.90 | 84.28 | 85.64 | 83.43 | 0.802 times |
06 Fri Sep 2024 | 84.08 | 91.21 | 92.81 | 83.73 | 7.111 times |
30 Fri Aug 2024 | 91.21 | 91.46 | 92.35 | 89.95 | 0.23 times |
30 Fri Aug 2024 | 91.21 | 90.45 | 93.04 | 88.61 | 0.725 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Monthly Closing Price | Open | High | Low | Volume |
18 Wed Sep 2024 | 71.14 | 91.21 | 92.81 | 68.83 | 1.032 times |
30 Fri Aug 2024 | 91.21 | 84.40 | 94.85 | 80.06 | 1.234 times |
31 Wed Jul 2024 | 84.33 | 82.83 | 86.80 | 80.53 | 0.324 times |
28 Fri Jun 2024 | 82.33 | 75.75 | 86.13 | 75.40 | 2.011 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 76.06 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 76.06 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.